Octavia Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Sell
12,117
-53
-0.4% -$4.44K 0.09% 69
2026
Q1
$975K Sell
12,170
-61
-0.5% -$5.03K 0.09% 76
2025
Q4
$1.04M Sell
12,231
-121
-1% -$9.93K 0.1% 79
2025
Q3
$961K Hold
12,352
0.1% 86
2025
Q2
$966K Sell
12,352
-71
-0.6% -$5.29K 0.11% 74
2025
Q1
$900K Sell
12,423
-12
-0.1% -$859 0.11% 77
2024
Q4
$921K Sell
12,435
-17
-0.1% -$1.19K 0.11% 78
2024
Q3
$822K Hold
12,452
0.1% 84
2024
Q2
$1.15M Sell
12,452
-89
-0.7% -$7.88K 0.16% 66
2024
Q1
$1.2M Buy
12,541
+106
+0.9% +$8.9K 0.18% 66
2023
Q4
$948K Sell
12,435
-50
-0.4% -$3.48K 0.17% 76
2023
Q3
$865K Buy
12,485
+32
+0.3% +$2.57K 0.18% 72
2023
Q2
$1.17M Sell
12,453
-274
-2% -$23.8K 0.24% 57
2023
Q1
$1.05M Buy
12,727
+430
+3% +$33.8K 0.24% 56
2022
Q4
$917K Hold
12,297
0.23% 65
2022
Q3
$1.02M Sell
12,297
-34
-0.3% -$3.27K 0.27% 59
2022
Q2
$1.17M Sell
12,331
-76
-0.6% -$7.87K 0.31% 57
2022
Q1
$1.46M Buy
+12,407
New +$1.39M 0.32% 50

Other funds holding EW

Octavia Wealth Advisors's EW Position: Q2 2026 in Review

Octavia Wealth Advisors reduced its Edwards Lifesciences (EW) stake by 0.44% in Q2 2026, selling an estimated $4.44K and leaving 12,117 shares worth $1.1M. The position accounts for 0.09% of the portfolio, ranked #69.

Octavia Wealth Advisors first reported a position in EW in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.46M in Q1 2022. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Octavia Wealth Advisors held 12,117 shares of Edwards Lifesciences worth $1.1M as of Q2 2026.
  • Octavia Wealth Advisors sold 53 Edwards Lifesciences shares in Q2 2026, an estimated $4.44K.
  • Edwards Lifesciences made up 0.09% of Octavia Wealth Advisors's portfolio in Q2 2026, its #69 holding.
  • Octavia Wealth Advisors first reported a position in Edwards Lifesciences in Q1 2022 and has held it in 18 quarters since.
  • Octavia Wealth Advisors's Edwards Lifesciences position peaked at $1.46M in Q1 2022.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Octavia Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.